Regeneron Pharmaceuticals shares owned by Chesley, Taft & Associates
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Chesley, Taft & Associates
from 13F filings
Historical chart of Chesley, Taft & Associates investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Chesley, Taft & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Regeneron Pharmaceuticals by Chesley, Taft & Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $510k | 485 | 1051.24 |
2024-06-30 | $510k | 485 | 1051.03 |
2024-03-31 | $467k | 485 | 962.49 |
2023-12-31 | $426k | 485 | 878.29 |
2023-09-30 | $399k | 485 | 822.96 |
2023-06-30 | $349k | 485 | 718.54 |
2023-03-31 | $399k | 485 | 821.67 |
2022-12-31 | $350k | 485 | 721.49 |
2022-09-30 | $334k | 485 | 688.66 |
2022-06-30 | $626k | 1.1k | 591.12 |
2022-03-31 | $737k | 1.0k | 716.23 |
2021-12-31 | $650k | 1.0k | 631.68 |
2021-09-30 | $559k | 923 | 605.63 |
2021-06-30 | $516k | 923 | 559.05 |
2021-03-31 | $474k | 978 | 484.66 |
2020-12-31 | $567k | 1.2k | 483.38 |
2020-09-30 | $657k | 1.2k | 560.10 |
2020-06-30 | $919k | 1.5k | 623.90 |
2020-03-31 | $719k | 1.5k | 488.12 |
2019-12-31 | $534k | 1.4k | 375.26 |
2019-09-30 | $404k | 1.5k | 277.66 |
2019-06-30 | $400k | 1.3k | 312.99 |
2019-03-31 | $1.6M | 3.8k | 410.75 |
2018-12-31 | $1.4M | 3.9k | 373.57 |
2018-09-30 | $1.8M | 4.4k | 404.00 |
2018-06-30 | $1.5M | 4.4k | 345.09 |
2018-03-31 | $1.6M | 4.5k | 344.45 |
2017-12-31 | $1.7M | 4.6k | 375.87 |
2017-09-30 | $2.1M | 4.6k | 447.17 |
2017-06-30 | $2.3M | 4.6k | 491.24 |
2017-03-31 | $1.8M | 4.6k | 387.46 |
2016-12-31 | $1.7M | 4.6k | 367.14 |
2016-09-30 | $1.9M | 4.8k | 402.01 |
2016-06-30 | $1.7M | 5.0k | 349.32 |
2016-03-31 | $1.8M | 5.0k | 360.51 |
2015-12-31 | $5.3M | 9.7k | 542.82 |
2015-09-30 | $5.1M | 11k | 465.12 |
2015-06-30 | $5.9M | 12k | 510.10 |
2015-03-31 | $5.8M | 13k | 451.48 |
2014-12-31 | $5.3M | 13k | 410.27 |
2014-09-30 | $4.7M | 13k | 360.55 |
2014-06-30 | $3.8M | 13k | 282.47 |
2014-03-31 | $4.0M | 13k | 300.30 |
2013-12-31 | $3.7M | 13k | 275.22 |
2013-09-30 | $4.2M | 14k | 312.85 |
2013-06-30 | $5.2M | 23k | 224.88 |
2013-03-31 | $4.1M | 23k | 176.40 |
2012-12-31 | $4.3M | 25k | 171.08 |
2012-09-30 | $4.2M | 27k | 152.68 |
2012-06-30 | $3.1M | 27k | 114.23 |
2012-03-31 | $3.2M | 28k | 116.61 |
2011-12-31 | $1.6M | 28k | 55.43 |
2011-09-30 | $1.7M | 29k | 58.21 |
2011-06-30 | $2.3M | 41k | 56.70 |
2011-03-31 | $2.6M | 57k | 44.93 |
2010-12-31 | $1.9M | 57k | 32.83 |
More positions owned by Chesley, Taft & Associates
View all positions for Chesley, Taft & Associates